Stock screener


All disclosures →
EDGAR →
ABT
Conviction 34HealthcareScan · Thu, Jun 25, 2026ABT$93.25+3.04%
ResistanceSupportVol 14Insider buyCongress buyCongress sellVol MA14 18.82M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +0.00%· 1 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price93.25
Change+3.04%
Gap+0.12%
Rel volume4.79×
Avg volume17.01M
Avg $ vol1.53B
SMA 2089.13
SMA 5089.27
SMA 200112.80
Price vs 50+4.45%
Price vs 200-17.33%
MA stackmixed
50/200 cross—
Supertrendup · 85.41
RSI (14)61
MACD hist0.48
MACD cross—
Stoch %K / %D82 / 68
ADX (14)20
+DI / −DI31 / 16
RSI divergence—
MACD divergence—
ATR %+2.53%
ADR %2.35%
52w high137.40
52w low82.56
From 52w high-32.14%
Above 52w low+12.94%
New 52w highNo
SqueezeOff
Bollinger width8.48%
%B1.05
Donchian pos86.04%
Donchian high94.56
Donchian low85.14
AVWAP (52w high)110.38
vs AVWAP high-15.52%
AVWAP (52w low)88.51
vs AVWAP low+5.34%
OBV trendFlat
Chaikin MF (20)-0.00
Today vs 20d4.79×
Avg vol (14d)18.82M
Avg vol (20d)17.01M
Avg $ vol (20d)1.53B
Market cap162.42B
RS 3m (vs SPY)-25.30%
RS 6m (vs SPY)-35.60%
RS line new highNo
Trend template1/8
Technical rank42.9
1 week+5.36%
1 month+7.59%
3 months-11.05%
6 months-25.52%
1 year-32.47%
YTD-24.92%
P/E24.89
P/B3.12
P/S3.66
P/FCF21.96
EPS3.72
Div yield2.53%
ROE12.53%
ROA5.91%
Debt/Eq0.65
Current1.39
EV/EBITDA—
Gross margin9.92%
Net margin14.72%
Rev growth5.67%
EPS growth-51.32%
Price target117.75
Target upside26.28%
Analyst ratingBuy
Institutional91.13%
Ent. value189.66B
Revenue11.16B
Net income1.08B
Gross profit—
Free cash flow7.39B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out1.74B
Employees115K
ListedTue, Apr 19, 1949
Free float1.73B
Float %99.5%
Short interest22.04M
Days to cover1.9d
Short volume27.6%
Squeeze score27 / 100
Next earningsThu, Jul 16, 2026 (21d)
EPS forecast$1.28 · 7 est
Last EPS vs est$1.15 vs $1.14
Last surprise+0.9% beat
Setup gradeD
Conviction34 / 100
Pattern quality—
Tech rank42.9 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance92.16
Support83.47
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ABT · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Julie Johnson house · D · TX · traded 2026-05-12 | Sell | $1K–$15K | 2026-05-12 | 2026-06-12 | |
Gilbert Cisneros house · CA · traded 2026-05-15 | Sell | $1K–$15K | 2026-05-15 | 2026-06-05 | |
Richard W. Allen house · GA · traded 2026-04-16 | Sell | ≥ $15K | 2026-04-16 | 2026-05-04 | |
Laura Friedman house · CA · traded 2026-03-24 | Exchange | $1K–$15K | 2026-03-24 | 2026-04-03 | |
Julie Johnson house · TX · traded 2025-12-18 | Sell | $1K–$15K | 2025-12-18 | 2026-01-05 | |
Byron Donalds house · FL · traded 2025-12-04 | Sell | $1K–$15K | 2025-12-04 | 2026-01-01 | |
Rick Larsen house · D · WA · traded 2025-10-06 | Buy | $1K–$15K | 2025-10-06 | 2025-10-16 | |
Richard Dean Dr McCormick house · R · GA · traded 2023-03-15 | Buy | $1K–$15K | 2023-03-15 | 2025-09-17 | |
Julie Johnson house · D · TX · traded 2025-08-14 | Sell | $1K–$15K | 2025-08-14 | 2025-09-11 | |
Thomas H. Kean house · R · NJ · traded 2025-07-21 | Buy | $1K–$15K | 2025-07-21 | 2025-08-20 |
Insider activity
SEC Form 4 transactions in ABT · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Stratton John G Director · Common shares without par value · 2026-05-07 | Buy | 2K | $174K | 2026-05-07 | 2026-06-18 |
Moreland Mary K EXECUTIVE VICE PRESIDENT · Common shares without par value · 2026-04-28 | Acquire | 5.31K | $502K | 2026-04-28 | 2026-04-29 |
Moreland Mary K EXECUTIVE VICE PRESIDENT · Common shares without par value · 2026-04-28 | Other | — | — | 2026-04-28 | 2026-04-29 |
STARKS DANIEL J Director · Common shares without par value · 2026-04-27 | Buy | 10K | $927K | 2026-04-27 | 2026-04-28 |
O'Grady Michael Director · Option (right to buy) · 2026-04-24 | Grant | 5.93K | $0 | 2026-04-24 | 2026-04-28 |
Babineaux-Fontenot Claire Director · Common shares without par value · 2026-04-24 | Grant | 2.29K | $0 | 2026-04-24 | 2026-04-28 |
McKinstry Nancy Director · Common shares without par value · 2026-04-24 | Grant | 2.29K | $0 | 2026-04-24 | 2026-04-28 |
Ahuja Nita Director · Common shares without par value · 2026-04-24 | Grant | 2.29K | $0 | 2026-04-24 | 2026-04-28 |
O'Grady Michael Director · Common shares without par value · 2026-04-24 | Grant | 2.29K | $0 | 2026-04-24 | 2026-04-28 |
McKinstry Nancy Director · Option (right to buy) · 2026-04-24 | Grant | 2.31K | $0 | 2026-04-24 | 2026-04-28 |
SEC filings
EDGAR filings in ABT
No recent SEC filings on file for ABT.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.